solifenacin succinate has been researched along with Cognitive Dysfunction in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantas, LP; Forte, ARCC; Lessa, PHC; Lima, BC; Patrocínio, MCA; Sousa, CNS; Vasconcelos, EC; Vasconcelos, SMM; Vieira, RF | 1 |
| Duong, V; Iglesia, C; Iwamoto, A; Kudish, B; Pennycuff, J | 1 |
| Panicker, JN; Richardson, K; Welk, B | 1 |
| Compion, G; Dale, M; Stow, B; Tretter, R; Wagg, A | 2 |
| Cornu, JN | 1 |
3 review(s) available for solifenacin succinate and Cognitive Dysfunction
| Article | Year |
|---|---|
Treatment of bladder dysfunction with solifenacin: is there a risk of dementia or cognitive impairment?
Topics: Aged; Cognitive Dysfunction; Dementia; Humans; Solifenacin Succinate; Urinary Bladder; Urinary Bladder, Overactive | 2022 |
A systematic review of neurocognitive dysfunction with overactive bladder medications.
Topics: Aged; Cognitive Dysfunction; Humans; Muscarinic Antagonists; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2021 |
The cognitive effect of anticholinergics for patients with overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cognition; Cognitive Dysfunction; Dementia; Humans; Mandelic Acids; Prodromal Symptoms; Pyrrolidines; Risk Assessment; Risk Factors; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2021 |
1 trial(s) available for solifenacin succinate and Cognitive Dysfunction
| Article | Year |
|---|---|
Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
Topics: Age Factors; Aged; Aged, 80 and over; Aging; Analysis of Variance; Attention; Cognition; Cognitive Dysfunction; Cross-Over Studies; Double-Blind Method; Female; Humans; Least-Squares Analysis; Male; Mandelic Acids; Memory; Muscarinic Antagonists; Quinuclidines; Risk Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2013 |
2 other study(ies) available for solifenacin succinate and Cognitive Dysfunction
| Article | Year |
|---|---|
Reply from authors re: Jean-Nicolas Cornu. Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg. Eur Urol 2013;64:82-3.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |
Overactive bladder medical management in the elderly: it is time to go beyond the tip of the iceberg.
Topics: Aging; Cognition; Cognitive Dysfunction; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Urinary Bladder, Overactive; Urological Agents | 2013 |